| Abstrakt: |
Keywords: BRCA1; Breast Cancer; Cancer; Combined Modality Therapy; Drugs and Therapies; Genetics; Health and Medicine; Neoadjuvant Therapy; Oncology; Pharmaceuticals; Women's Health EN BRCA1 Breast Cancer Cancer Combined Modality Therapy Drugs and Therapies Genetics Health and Medicine Neoadjuvant Therapy Oncology Pharmaceuticals Women's Health 2023 FEB 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Researchers detail new data in breast cancer. N.N. Petrov Institute of Oncology Researchers Highlight Research in Breast Cancer (Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study...) BRCA1, Breast Cancer, Cancer, Combined Modality Therapy, Drugs and Therapies, Genetics, Health and Medicine, Neoadjuvant Therapy, Oncology, Pharmaceuticals, Women's Health. [Extracted from the article] |
